Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma.
biomarkers
ccRCC
circulating miRNAs
liquid biopsies
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
28 07 2021
28 07 2021
Historique:
received:
22
06
2021
revised:
26
07
2021
accepted:
26
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
10
2
2022
Statut:
epublish
Résumé
microRNAs (miRNAs) are emerging as relevant molecules in cancer development and progression. MiRNAs add a post-transcriptional level of control to the regulation of gene expression. The deregulation of miRNA expression results in changing the molecular circuitry in which miRNAs are involved, leading to alterations of cell fate determination. In this review, we describe the miRNAs that are emerging as innovative molecular biomarkers from liquid biopsies, not only for diagnosis, but also for post-surgery management in cancer. We focus our attention on renal cell carcinoma, in particular highlighting the crucial role of circulating miRNAs in clear cell renal cell carcinoma (ccRCC) management. In addition, the functional deregulation of miRNA expression in ccRCC is also discussed, to underline the contribution of miRNAs to ccRCC development and progression, which may be relevant for the identification and design of innovative clinical strategies against this tumor.
Identifiants
pubmed: 34440329
pii: genes12081154
doi: 10.3390/genes12081154
pmc: PMC8391131
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Sci Rep. 2014 Dec 18;4:7546
pubmed: 25519054
Oncotarget. 2017 Dec 7;9(12):10317-10323
pubmed: 29535809
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Clin Cancer Res. 2021 Jan 1;27(1):78-86
pubmed: 32873572
Cell Physiol Biochem. 2018;49(5):1755-1765
pubmed: 30231239
J Cell Physiol. 2020 Jun;235(6):5008-5029
pubmed: 31724738
Urol Oncol. 2017 May;35(5):294-299
pubmed: 28089386
Br J Cancer. 2017 Oct 10;117(8):1202-1210
pubmed: 28809863
Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4557-4565
pubmed: 29131260
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10699-10707
pubmed: 31858538
Physiol Rep. 2017 Jun;5(11):
pubmed: 28596300
Sci Rep. 2020 Dec 4;10(1):21290
pubmed: 33277569
Int J Mol Sci. 2021 Apr 01;22(7):
pubmed: 33916025
Int J Mol Sci. 2015 Dec 08;16(12):29219-25
pubmed: 26670229
Biomed Res Int. 2015;2015:125094
pubmed: 25874201
Adv Exp Med Biol. 2013;768:147-63
pubmed: 23224969
Nat Commun. 2017 Nov 24;8(1):1769
pubmed: 29176561
Clin Chem. 2010 Nov;56(11):1733-41
pubmed: 20847327
Oncol Rep. 2018 Dec;40(6):3416-3426
pubmed: 30272324
Aging (Albany NY). 2019 Aug 10;11(15):5705-5725
pubmed: 31400752
EBioMedicine. 2020 Jan;51:102622
pubmed: 31901870
Front Oncol. 2019 May 08;9:357
pubmed: 31139560
PLoS One. 2016 May 02;11(5):e0154130
pubmed: 27135244
Cancer Biomark. 2020;27(2):181-188
pubmed: 31771042
Oncogene. 2016 May;35(21):2789-800
pubmed: 26387538
J Exp Clin Cancer Res. 2020 Jun 1;39(1):98
pubmed: 32487203
J Chemother. 2013 Aug;25(4):229-38
pubmed: 23816136
RNA. 2014 Sep;20(9):1369-75
pubmed: 25002673
Oxid Med Cell Longev. 2017;2017:2712751
pubmed: 28607629
Breast Cancer Res. 2018 Jul 11;20(1):72
pubmed: 29996899
PLoS One. 2016 Feb 09;11(2):e0148746
pubmed: 26859141
Cancer. 2013 May 1;119(9):1618-26
pubmed: 23335180
Cardiovasc Res. 2008 Sep 1;79(4):553-61
pubmed: 18539629
Kaohsiung J Med Sci. 2021 Feb;37(2):121-127
pubmed: 33022894
Lab Invest. 2008 Dec;88(12):1358-66
pubmed: 18794849
J Drug Target. 2019 Jan;27(1):67-74
pubmed: 30183478
Biochim Biophys Acta Gen Subj. 2017 Sep;1861(9):2175-2185
pubmed: 28579513
Biochim Biophys Acta Mol Basis Dis. 2021 Apr 1;1867(4):166046
pubmed: 33383105
Kaohsiung J Med Sci. 2021 Mar;37(3):192-199
pubmed: 33151036
Nat Cell Biol. 2011 Apr;13(4):423-33
pubmed: 21423178
Eur Urol Focus. 2018 Apr;4(3):412-419
pubmed: 28753793
Int J Clin Exp Pathol. 2013 May 15;6(6):1086-94
pubmed: 23696926
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
Nat Rev Dis Primers. 2017 Mar 09;3:17009
pubmed: 28276433
Sci Rep. 2019 Sep 24;9(1):13772
pubmed: 31551516
J Physiol Biochem. 2011 Mar;67(1):129-39
pubmed: 20981514
Mol Cancer. 2019 Apr 11;18(1):86
pubmed: 30975145
Oncol Lett. 2018 Jan;15(1):271-277
pubmed: 29375712
Oncotarget. 2017 Jun 13;8(41):69551-69558
pubmed: 29050224
Future Oncol. 2019 Jul;15(20):2361-2370
pubmed: 31267758
Neoplasia. 2013 Feb;15(2):180-91
pubmed: 23441132
Cancer Prev Res (Phila). 2009 Sep;2(9):807-13
pubmed: 19723895
Int J Mol Sci. 2019 Mar 31;20(7):
pubmed: 30935143
Oncotarget. 2017 Mar 7;8(10):17328-17346
pubmed: 28061475
Ann Med. 2008;40(3):197-208
pubmed: 18382885
Transl Androl Urol. 2020 Jun;9(3):1314-1322
pubmed: 32676415
Nat Rev Clin Oncol. 2011 Jun 07;8(8):467-77
pubmed: 21647195
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Open Life Sci. 2020 Jun 11;15(1):389-399
pubmed: 33817227
Cancer Lett. 2017 May 28;394:1-12
pubmed: 28089832
Int J Oncol. 2018 Jul;53(1):257-265
pubmed: 29749434
PLoS One. 2017 Jun 29;12(6):e0180660
pubmed: 28662155
Future Sci OA. 2020 Feb 26;6(4):FSO465
pubmed: 32257377
Med Sci Monit. 2019 Jul 12;25:5181-5190
pubmed: 31299041
Asian Pac J Cancer Prev. 2016;17(4):1887-90
pubmed: 27221871
J Surg Oncol. 2014 Jun;109(7):676-83
pubmed: 24510588
Dis Markers. 2019 Dec 30;2019:5648783
pubmed: 31976022
N Engl J Med. 2005 Oct 27;353(17):1793-801
pubmed: 16251535
Int J Oncol. 2019 Feb;54(2):559-571
pubmed: 30483771
Cell. 2012 Mar 16;148(6):1172-87
pubmed: 22424228
Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4518-4523
pubmed: 30058684
Cancer Prev Res (Phila). 2010 Nov;3(11):1435-42
pubmed: 20959518
Annu Rev Pathol. 2009;4:199-227
pubmed: 18817506
Br J Cancer. 2017 Feb 28;116(5):634-639
pubmed: 28081549
Oncotarget. 2017 Jul 22;8(38):63703-63714
pubmed: 28969022
Mol Cell. 2007 Jun 8;26(5):611-23
pubmed: 17560368
Metab Brain Dis. 2021 Aug;36(6):1119-1134
pubmed: 33881724
J Cell Mol Med. 2019 Oct;23(10):6755-6765
pubmed: 31342628
Aging (Albany NY). 2019 Jan 22;11(2):615-633
pubmed: 30668544
Br J Haematol. 2008 May;141(5):672-5
pubmed: 18318758
PLoS One. 2015 May 04;10(5):e0125672
pubmed: 25938468
Oncol Rep. 2016 Jun;35(6):3178-84
pubmed: 27109339
Oncotarget. 2015 Sep 29;6(29):26971-81
pubmed: 26284486
Asia Pac J Clin Oncol. 2013 Mar;9(1):53-9
pubmed: 22898264
Sci Rep. 2015 Jan 05;5:7610
pubmed: 25556603
Mol Ther Oncolytics. 2020 May 26;18:47-57
pubmed: 32637580
Front Oncol. 2020 Nov 30;10:596359
pubmed: 33330087
World J Gastroenterol. 2015 Sep 14;21(34):9853-62
pubmed: 26379392
Leuk Res. 2013 Nov;37(11):1420-8
pubmed: 24054860
Cancer Biother Radiopharm. 2019 Jun;34(5):334-341
pubmed: 30844301
Eur Rev Med Pharmacol Sci. 2017 May;21(10):2357-2363
pubmed: 28617555
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Cell Cycle. 2015;14(4):481-7
pubmed: 25607528
J Cell Biochem. 2019 Feb;120(2):1492-1502
pubmed: 30304555
Clin Chim Acta. 2009 Feb;400(1-2):97-102
pubmed: 18996365
Annu Rev Biochem. 2010;79:351-79
pubmed: 20533884
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Mol Med Rep. 2019 Jul;20(1):604-612
pubmed: 31180541
Sci Signal. 2009 Dec 08;2(100):ra81
pubmed: 19996457
Int J Cancer. 2017 Nov 1;141(9):1730-1740
pubmed: 28639257
BMC Cancer. 2019 Aug 28;19(1):843
pubmed: 31455274
Cell Death Dis. 2021 Jan 4;12(1):33
pubmed: 33414440
J Cancer. 2019 Jun 9;10(15):3389-3396
pubmed: 31293642
EMBO J. 2004 Oct 13;23(20):4051-60
pubmed: 15372072
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):138-159
pubmed: 30602127
PLoS One. 2013 Oct 03;8(10):e76247
pubmed: 24098452
J Cancer. 2020 Jan 14;11(6):1614-1624
pubmed: 32047567
Urol Oncol. 2014 Jan;32(1):46.e9-17
pubmed: 24094887
Glycobiology. 2009 Apr;19(4):331-6
pubmed: 18948359
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):25036-25042
pubmed: 32943537
Mol Cancer. 2016 Dec 19;15(1):83
pubmed: 27993170
J Pathol. 2011 Jun;224(2):280-8
pubmed: 21465485
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
Cell Death Dis. 2019 Jan 8;10(1):17
pubmed: 30622242
Tumour Biol. 2014 May;35(5):4057-66
pubmed: 24379138
Respir Res. 2014 Nov 25;15:149
pubmed: 25421010
Cell Physiol Biochem. 2016;39(4):1512-20
pubmed: 27614739
Clin Lung Cancer. 2009 Jan;10(1):42-6
pubmed: 19289371
Mol Cancer. 2019 Nov 1;18(1):151
pubmed: 31672157
Breast Cancer Res Treat. 2012 Aug;134(3):933-41
pubmed: 22350790
Lung Cancer (Auckl). 2016 Mar 02;7:19-27
pubmed: 28210157
Front Cell Dev Biol. 2020 Jan 22;7:360
pubmed: 32039195
J Transl Med. 2020 Feb 11;18(1):69
pubmed: 32046742
Mol Cancer. 2018 Mar 6;17(1):70
pubmed: 29510731
Exp Biol Med (Maywood). 2017 Jun;242(12):1299-1305
pubmed: 28429654
Lung Cancer. 2014 Aug;85(2):197-204
pubmed: 24863004
BMC Cell Biol. 2015 Nov 17;16:27
pubmed: 26577150
Cancer Biomark. 2021;30(3):343-351
pubmed: 33337348
Annu Rev Cell Dev Biol. 2007;23:175-205
pubmed: 17506695
Curr Urol Rep. 2020 Mar 13;21(2):11
pubmed: 32166474
Nat Struct Mol Biol. 2018 Nov;25(11):1019-1027
pubmed: 30297778
J Cell Physiol. 2018 Sep;233(9):6866-6877
pubmed: 29319175
Clin Cancer Res. 2014 Apr 1;20(7):1779-90
pubmed: 24486593
Cancer Lett. 2020 Mar 1;472:50-58
pubmed: 31862408
Onco Targets Ther. 2019 Jan 25;12:849-859
pubmed: 30774372
Onco Targets Ther. 2021 Jan 13;14:393-402
pubmed: 33469315
Int J Oncol. 2014 Jan;44(1):53-8
pubmed: 24212760
Mol Diagn Ther. 2020 Apr;24(2):215-232
pubmed: 32112368
Clin Epigenetics. 2018 Jan 23;10:11
pubmed: 29410711
PLoS One. 2010 Oct 20;5(10):e13515
pubmed: 20976003
Sci Rep. 2020 Jul 29;10(1):12705
pubmed: 32728103
J Cancer Res Ther. 2019 Jan-Mar;15(1):115-119
pubmed: 30880765
World J Gastroenterol. 2018 Jul 7;24(25):2647-2660
pubmed: 29991871
Cancer Biol Ther. 2016;17(1):79-82
pubmed: 26575977
Development. 2016 Dec 1;143(23):4324-4340
pubmed: 27802171
Front Immunol. 2015 May 04;6:203
pubmed: 25999947
Cell Commun Signal. 2009 Aug 10;7:18
pubmed: 19664273
Oncol Rep. 2015 Jun;33(6):2915-23
pubmed: 25962395
Oncol Lett. 2016 Sep;12(3):2194-2200
pubmed: 27602163
Biochem J. 2017 May 4;474(10):1603-1618
pubmed: 28473628
PLoS One. 2008;3(11):e3694
pubmed: 19002258
Cell Cycle. 2014;13(2):227-39
pubmed: 24200968
Cancer Sci. 2021 Apr;112(4):1443-1456
pubmed: 33453148
J Neurooncol. 2013 Jan;111(1):71-81
pubmed: 23104517
Mol Cancer Ther. 2012 Apr;11(4):842-52
pubmed: 22343731
Sci Rep. 2019 Mar 1;9(1):3207
pubmed: 30824757
Biomed Res Int. 2018 Dec 06;2018:1972606
pubmed: 30627543
Oncogene. 2021 Mar;40(9):1674-1689
pubmed: 33510354